Minimal Residual Disease (MRD) Status in FCR-Treated CLL Patients at the End of Treatment Influences Progression Free Survival (PFS), Results of the Ctrial-IE (ICORG) 07-01/ CLL Ireland Study, with Mutational Analysis Providing Additional Insight

Autor: Appleby, Niamh *, Quinn, Fiona M *, O'Brien, David *, Liam, Smyth *, Kelly, Johanna *, Parker, Imelda *, Scott, Kathleen *, Cahill, Mary R *, Crotty, Gerard *, Enright, Helen *, Hennessy, Brian *, Hodgson, Andrew, Leahy, Maeve *, O'Leary, Hilary M *, O'Dwyer, Michael E, Hayat, Amjad, Vandenberghe, Elisabeth A.
Zdroj: In Blood 2 December 2016 128(22):3237-3237
Databáze: ScienceDirect